(-0.52%) 5 040.75 points
(-0.25%) 37 899 points
(-0.85%) 17 423 points
(-1.37%) $80.81
(-3.11%) $1.929
(-0.01%) $2 302.60
(0.40%) $26.76
(0.54%) $953.30
(0.00%) $0.937
(-0.01%) $11.09
(0.08%) $0.801
(0.01%) $93.46
-0.51% ¥ 2 908.00
Live Chart Being Loaded With Signals
BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies...
Stats | |
---|---|
Dagens volum | 35 700.00 |
Gjennomsnittsvolum | 84 044.00 |
Markedsverdi | 113.37B |
EPS | ¥0 ( 2024-02-08 ) |
Neste inntjeningsdato | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥20.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 15.24 |
ATR14 | ¥1.734 (0.06%) |
Volum Korrelasjon
BML, Inc. Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
BML, Inc. Korrelasjon - Valuta/Råvare
BML, Inc. Økonomi
Annual | 2022 |
Omsetning: | ¥159.46B |
Bruttogevinst: | ¥61.45B (38.53 %) |
EPS: | ¥395.83 |
FY | 2022 |
Omsetning: | ¥159.46B |
Bruttogevinst: | ¥61.45B (38.53 %) |
EPS: | ¥395.83 |
FY | 2022 |
Omsetning: | ¥186.07B |
Bruttogevinst: | ¥86.95B (46.73 %) |
EPS: | ¥833.24 |
FY | 2021 |
Omsetning: | ¥138.57B |
Bruttogevinst: | ¥54.77B (39.52 %) |
EPS: | ¥337.44 |
Financial Reports:
No articles found.
BML, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥40.00 (N/A) |
¥0 (N/A) |
¥20.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥3.75 | 2001-09-25 |
Last Dividend | ¥20.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 45 | -- |
Total Paid Out | ¥566.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.38 | |
Div. Directional Score | 7.58 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8242.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7609.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
6807.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6151.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4887.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4062.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3282.T | Ex Dividend Junior | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
2325.T | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
9267.T | Ex Dividend Knight | 2023-12-19 | Semi-Annually | 0 | 0.00% | |
8014.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0529 | 1.500 | 8.94 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0444 | 1.200 | 8.52 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0606 | 1.500 | -0.437 | -0.656 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.46 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.20 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.40 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0211 | -1.500 | 9.65 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 288.28 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 344.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 344.19 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0286 | -1.500 | 9.89 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.340 | 1.000 | 7.67 | 7.67 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0799 | 1.000 | -0.402 | -0.402 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 3.79 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.840 | 0.800 | 7.73 | 6.19 | [0.5 - 2] |
Total Score | 11.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 15.16 | 1.000 | 8.57 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0606 | 2.50 | -0.281 | -0.656 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 344.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.76 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 344.19 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.103 | 1.500 | -2.65 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0953 | 1.000 | -0.117 | 0 | [0.1 - 0.5] |
Total Score | 3.38 |
BML, Inc.
BML, Inc. provides laboratory testing and related services in Japan. The company offers general laboratory tests, including biochemical and hematologic examinations; special laboratory tests, such as RIA, cellular, immunological, and DNA analysis; microbiological tests for medical and pharmaceutical societies and organizations; and laboratory tests in tumorology, infectious disease, diabetes, hypertension, allergy, and genetic studies. It also develops Frontier and Symphony automation systems, which automate pre-processing procedures from sorting to dispensing, and subsequent test procedures; and provides electronic medical charts for networking medical information, as well as offers preventive medicine services. In addition, the company provides food sanitation control and food processing services comprising contract services for microorganism testing of raw materials, and prepared and processed foods; environmental hygiene testing of food processing facilities and kitchens; and microorganism testing services, as well as assesses genetically modified organisms. Further, it provides drinking water and waste water tests; work sanitation management services, such as measurement of ethylene oxide gas, formaldehyde, organic solvents, and dust; environmental monitoring services, including measurement of indoor contaminants and other indoor environmental variables; and biological dioxin monitoring services. Additionally, the company offers analysis services for residual agricultural chemicals; dental test services for dental caries and periodontal diseases; consulting services for the approval of pharmaceuticals; investigative analysis services to pharmaceutical manufacturers; and gene expression analysis and testing for genes that cause susceptibility to infectious diseases. BML, Inc. was founded in 1955 and is headquartered in Tokyo, Japan.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.